{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:40:33Z","timestamp":1790304033606,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004296","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2005,7,20]],"date-time":"2005-07-20T00:00:00Z","timestamp":1121817600000}}],"reference-count":74,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004296.pub2","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T17:18:45Z","timestamp":1120497525000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Triflusal for preventing serious vascular events in people at high risk"],"prefix":"10.1002","author":[{"given":"Jo\u00e3o","family":"Costa","sequence":"first","affiliation":[{"name":"Faculdade de Medicina de Lisboa; Laborat\u00f3rio de Farmacologia Cl\u00ednica e Terap\u00eautica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Ferro","sequence":"additional","affiliation":[{"name":"Santa Maria Hospital; Department of Neurology; Av Prof Egas Moniz Lisboa Portugal 1649-045"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Matias-Guiu","sequence":"additional","affiliation":[{"name":"Hospital General Universitario de Alicante; Service of Neurology; Maestro Alonso 109 Alicante Spain E03010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Alvarez-Sabin","sequence":"additional","affiliation":[{"name":"Vall d'Hebron Hospital; Department of Neurology; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[{"name":"Universitat Autonoma de Barcelona; Laboratorio de Bioestadistica y Epidemiologia; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,20]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0001|cit1","first-page":"57","article-title":"Triflusal in the treatment of patients with chronic peripheral arteriopathy: Multicentre double-blind clinical study vs placebo","volume":"15","author":"Auteri","year":"1995","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0002|cit2","first-page":"571","article-title":"Triflusal in the treatment of patients with chronic peripheral arteriopathy","volume":"43","author":"Forconi S per il Gruppo de Studio Multicentrico","year":"1995","journal-title":"Giornale di Gerontologia"},{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0167-5273(94)90040-X","article-title":"Outcome of patients with diabetes and unstable angina. A subgroup analysis in the Spanish Multicentre Trial of trifusal in unstable angina","volume":"46","author":"Garcia-Rubira","year":"1994","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0004|cit4","first-page":"32","article-title":"Triflusal in the prevention of myocardial infarction in unstable angina: multicentre national study","volume":"44 (Suppl 1)","author":"Grupo Espa\u00f1ol Angina Inestable-Triflusal","year":"1991","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"issue":"6","key":"10.1002\/14651858.CD004296.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000175892","article-title":"Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial","volume":"82","author":"Plaza","year":"1993","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0007|cit6","first-page":"288A (Abstract","article-title":"The efficacy and safety of low-dose aspirin versus triflusal in the long-term outcome of young stroke patients","volume":"44 (Suppl 2)","author":"Matias Guiu","year":"1994","journal-title":"Neurology"},{"issue":"147","key":"10.1002\/14651858.CD004296.pub2-BIB0008|cit7","first-page":"1669","article-title":"Comparative study of the effect of low-dosage acetylsalicylic acid and triflusal in the prevention of cardiovascular events among young adults with ischemic cerebrovascular disease","volume":"25","author":"Matias Guiu","year":"1997","journal-title":"Revista de Neurologia"},{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0009|cit8","first-page":"94","article-title":"Comparative study of the effect of low-dose aspirin and triflusal in the prevention of cardiovascular events in young adults with ischaemic cerebrovascular disease","volume":"14","author":"Matias Guiu","year":"1998","journal-title":"Acta Neurol\u00f3gica Colombiana"},{"issue":"1","key":"10.1002\/14651858.CD004296.pub2-BIB0010|cit9","first-page":"28","article-title":"Comparative study of the effect of low-dose aspirin and triflusal in the prevention of cardiovascular events in young adults with ischaemic cerebrovascular disease","volume":"7","author":"Matias Guiu","year":"1998","journal-title":"Revista Ecuatoriana de Neurologia"},{"issue":"147","key":"10.1002\/14651858.CD004296.pub2-BIB0011|cit10","first-page":"1669","article-title":"A comparative study of the effects of low doses of acetylsalicyclic acid and triflusal in the prevention of cardiovascular incidents in young adults with ischemic cerebrovascular disease","volume":"25","author":"Matias-Guiu","year":"1997","journal-title":"Revista Brasileira de Neurologia"},{"issue":"160","key":"10.1002\/14651858.CD004296.pub2-BIB0006|cit11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.33588\/rn.27160.98266","article-title":"The risk of hemorrhage in long-term use of aspirin and triflusal","volume":"27","author":"\u00c1lvarez Sab\u00edn","year":"1998","journal-title":"Revista de Neurologia"},{"issue":"10","key":"10.1002\/14651858.CD004296.pub2-BIB0013|cit12","first-page":"563","article-title":"Triflusal in the prevention of cerebrovascular attacks","volume":"43","author":"Smirne","year":"1995","journal-title":"Giornale di Gerontologia"},{"issue":"1","key":"10.1002\/14651858.CD004296.pub2-BIB0012|cit13","first-page":"Abstract 53","article-title":"Triflusal and prevention of cerebrovascular attacks: double blind clinical study vs asa","volume":"241","author":"Smirne","year":"1994","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1099-1786(199809)3:3<119::AID-QAJ72>3.0.CO;2-U","article-title":"Auditing experiences in Spain and Portugal of a multinational, large scale phase IV study","volume":"3","author":"Dent","year":"1998","journal-title":"Quality Assurance Journal"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0015|cit15","first-page":"14","article-title":"Recurrence risk lower anti-clotting drug than aspirin","volume":"March 9","author":"Drug Week","year":"2001","journal-title":"Drug Week"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0022|cit16","unstructured":"Matias-Guiu J Triflusal vs acetylsalicyclic acid in secondary prevention of cerebral infarction - TACIP www.strokecenter.org\/trials\/list 2003"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0016|cit17","first-page":"76-77 (Abstract","article-title":"Triflusal Aspirin Cerebral Infarction Prevention (TACIP) Study","volume":"6 (Suppl 2)","author":"Matias-Guiu","year":"1996","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0018|cit18","unstructured":"Matias-Guiu J Ferro JM Alvarez-Sabin J for the TACIP Steering Commitee Triflusal Aspirin Cerebral Infarction Prevention (TACIP Study). Ongoing Clinical Trial 22nd International Joint Conference On Stroke And Cerebral Circulation 1997 Abstract CT10"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0017|cit19","first-page":"86 (Abstract OC","article-title":"Triflusal Aspirin Cerebral Infarction Prevention (TACIP Study). Ongoing Clinical Trial","volume":"8 (Suppl 4)","author":"Matias-Guiu","year":"1998","journal-title":"Cerebrovascular Disorders"},{"issue":"11","key":"10.1002\/14651858.CD004296.pub2-BIB0019|cit20","first-page":"2868 (Abstract","article-title":"Triflusal versus aspirin in secondary stroke prevention: results of TACIP Study","volume":"31","author":"Matias-Guiu","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"329 (Abstract 7","DOI":"10.1161\/str.32.suppl_1.329-b","article-title":"Triflusal versus aspirin in secondary stroke prevention: results of TACIP Study","volume":"32","author":"Matias-Guiu","year":"2001","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD004296.pub2-BIB0020|cit22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial","volume":"34","author":"Matias-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0023|cit23","first-page":"92 (Abstract P-","article-title":"Triflusal Aspirin Cerebral Infarction Prevention (TACIP) Study. Ongoing clinical trial","volume":"18 (Suppl C)","author":"TACIP Study Group","year":"1998","journal-title":"Methods And Findings In Experimental And Clinical Pharmacology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0024|cit24","first-page":"S46","article-title":"TACIP Study: comparison of triflusal and moderate doses of aspirin in prevention of stroke","volume":"5 (Suppl 1)","author":"The TACIP Study - Steering Committee","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0025|cit25","first-page":"74 (Abstract tr","article-title":"Combined analysis of triflusal in secondary prevention of stroke","volume":"11 (Suppl 4)","author":"Torres","year":"2001","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0030|cit26","doi-asserted-by":"crossref","unstructured":"Culebras A Triflusal vs aspirin for the prevention of infarction: randomized stroke study - TAPIRSS www.strokecenter.org\/trials\/list 2001","DOI":"10.1161\/str.32.suppl_1.377-b"},{"issue":"4","key":"10.1002\/14651858.CD004296.pub2-BIB0031|cit27","first-page":"271","article-title":"Triflusal: an effective antiplatelet agent with significantly lower hemorrhagic risk than ASA","volume":"19","author":"Culebras","year":"2001","journal-title":"Today's Therapeutic Trends"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0027|cit28","first-page":"S123 (Abstract","article-title":"Triflusal is preferable to aspirin for the secondary prevention of ischemic stroke","volume":"187 (Suppl 1)","author":"Culebras","year":"2001","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"377 (Abstract P","DOI":"10.1161\/str.32.suppl_1.377-b","article-title":"Triflusal vs Aspirin for the Prevention of Infarction: a Randomized Stroke Study (TAPIRSS)","volume":"32","author":"Culebras","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0026|cit30","doi-asserted-by":"crossref","first-page":"1073-80","DOI":"10.1212\/01.WNL.0000113757.34662.AA","article-title":"Triflusal vs aspirin for prevention of cerebral infarction. A randomized stroke study","volume":"62","author":"Culebras","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0029|cit31","doi-asserted-by":"crossref","first-page":"S191 (Abstract","DOI":"10.1016\/S0022-510X(97)85803-0","article-title":"Baseline characteristics of persons enrolled in TAPIRSS","volume":"150 (Suppl)","author":"Culebras","year":"1997","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0032|cit32","first-page":"S107-8 (Abstrac","article-title":"Triflusal versus aspirin for the prevention of infarction (TAPIRSS): a randomized stroke study","volume":"5 (Suppl 3)","author":"Symecko","year":"1998","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0033|cit33","first-page":"71 (Abstract EP","article-title":"Clinical trials in Latin America","volume":"7 (Suppl 4)","author":"Symecko","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0034|cit34","first-page":"74 (Abstract tr","article-title":"Combined analysis of triflusal in secondary prevention of stroke","volume":"11 (Suppl 4)","author":"Torres","year":"2001","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0035|cit35","first-page":"46","article-title":"Triflusal vs aspirin in acute myocardial infarction: protocol of study and preliminary data","volume":"46 (Suppl 1)","author":"Cruz-Fernandez","year":"1993","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"issue":"6","key":"10.1002\/14651858.CD004296.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/euhj.1999.1874","article-title":"Randomized comparative trial of triflusal and aspirin following acute myocardial infarction","volume":"21","author":"Cruz-Fernandez","year":"2000","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD004296.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00019053-200220030-00005","article-title":"Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction","volume":"20","author":"Darba","year":"2002","journal-title":"Pharmacoeconomics"},{"issue":"134","key":"10.1002\/14651858.CD004296.pub2-BIB0038|cit38","first-page":"1306","article-title":"The tolerance of two therapeutic uses of triflusal in patients with ischemic stroke and triflusal","volume":"24","author":"Alvarez-Sabin","year":"1996","journal-title":"Revista de Neurologia"},{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0039|cit39","first-page":"51","article-title":"Clinico-biological effectiveness of triflusal during the postoperative period of patients with chronic ischemic syndrome of the extremities","volume":"25","author":"Arcas","year":"1981","journal-title":"Revista de Medicina de la Universidad de Navarra"},{"issue":"F","key":"10.1002\/14651858.CD004296.pub2-BIB0040|cit40","first-page":"F19","article-title":"Incidence of vascular stroke in patients with acute myocardial infarction receiving fibrinolytic treatment","volume":"1","author":"Lopez-Bescos","year":"1999","journal-title":"European Heart Journal Supplements"},{"issue":"6","key":"10.1002\/14651858.CD004296.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/000331979905000603","article-title":"Effects of triflusal on arteriosclerosis progression assessed with high-resolution arterial ultrasound","volume":"50","author":"Cesarone","year":"1999","journal-title":"Angiology"},{"issue":"6","key":"10.1002\/14651858.CD004296.pub2-BIB0042|cit42","first-page":"279","article-title":"Long-term clinical and biological study of a thrombocyte antiaggregant (Triflusal) in patients with progressive atherosclerosis","volume":"36","author":"Torre","year":"1984","journal-title":"Angiologia (Spain)"},{"issue":"4","key":"10.1002\/14651858.CD004296.pub2-BIB0043|cit43","first-page":"63","article-title":"Multicenter clinical study on acceptability of triflusal in prevention of cerebral vascular accident","volume":"3","author":"Garay Lillo","year":"1987","journal-title":"Geriatrika (Spain)"},{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.eurheartj.a059456","article-title":"Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: A randomized, double-blind, placebo-controlled trial","volume":"10","author":"Guiteras","year":"1989","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD004296.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12793\/jkscpt.1996.4.1.20","article-title":"A clinical trial on the safety and the inhibitory effect of platelet aggregation by triflusal (Disgren(TM)) in the patients with cerebral thrombosis","volume":"4","author":"Kwon","year":"1996","journal-title":"Journal of Korean Society for Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00042737-200302000-00011","article-title":"Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs","volume":"15","author":"Lanas","year":"2003","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD004296.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/030006059101900509","article-title":"Antiplatelet agents and their effect on complications during or soon after percutaneous transluminal coronary angioplasty","volume":"19","author":"Masotti","year":"1991","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD004296.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1653784","article-title":"Platelet count, antiplatelet therapy and pulmonary embolism - A prospective study in patients with hip surgery","volume":"73","author":"Monreal","year":"1995","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0049|cit49","unstructured":"P\u00e9rez-G\u00f3mez F Alegr\u00eda E Berj\u00f3n J A Iriarte J Zumalde J Salvador A Comparative effects of antiplatelet, anticoagulant or combined therapy in patients with valvular and non-valvular atrial fibrillation. A randomised multi-centre study Journal of the American College of Cardiology (accepted for publication)"},{"issue":"5","key":"10.1002\/14651858.CD004296.pub2-BIB0050|cit50","first-page":"541","article-title":"Platelet aggregation in different antithrombotic regimens. Possible proaggregant effect of low level oral anticoagulation","volume":"21","author":"Perez Gomez","year":"2002","journal-title":"Revista Portuguesa de Cardiologia"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0051|cit51","first-page":"79 (Abstract 30","article-title":"Aspirin but not triflusal increased antihypertensive therapy requirements during long term antiplatelet treatment","volume":"89 (Suppl 1)","author":"Pontes","year":"2001","journal-title":"Pharmacology and Toxicology"},{"issue":"6","key":"10.1002\/14651858.CD004296.pub2-BIB0052|cit52","first-page":"269","article-title":"Triflusal versus acetylsalicylic acid: a double-blind study for the prophylaxis of deep vein thrombosis after hip surgery","volume":"91","author":"Putz","year":"1991","journal-title":"Acta Chirurgica Belgica"},{"issue":"2","key":"10.1002\/14651858.CD004296.pub2-BIB0053|cit53","first-page":"71","article-title":"Clinical and biologic evaluation of triflusal in arteriosclerotic patients with high risk of thrombosis. Long-term study","volume":"33","author":"Sala-Planell","year":"1981","journal-title":"Angiologia (Spain)"},{"issue":"3","key":"10.1002\/14651858.CD004296.pub2-BIB0054|cit54","first-page":"263","article-title":"Compliance of geriatric patients subjected to antiplatelet agents with Triflusal in peripheral arteriopathy. Preliminary data","volume":"50","author":"Zan","year":"2002","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Altman DG Deeks JJ Meta-analysis, Simpson's paradox, and the number needed to treat BMC Medical Research Methodology 2002 3","DOI":"10.1186\/1471-2288-2-3"},{"issue":"6923","key":"10.1002\/14651858.CD004296.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","article-title":"Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004296.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jnnp.53.1.16","article-title":"A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project - 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage","volume":"53","author":"Bamford","year":"1990","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"9038","key":"10.1002\/14651858.CD004296.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/euhj.1999.1874","article-title":"Randomized comparative trial of triflusal and aspirin following acute myocardial infarction","volume":"21","author":"Cruz-Fernandez","year":"2000","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-0609.1988.tb00829.x","article-title":"Effects of triflusal and acetylsalycilic acid on platelet aggregation in whole blood of diabetic patients","volume":"40","author":"Cruz","year":"1988","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/BF00193701","article-title":"Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers","volume":"47","author":"Cruz","year":"1995","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0063|cit63","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in health Care: Meta-Analysis in context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0065|cit65","first-page":"753","article-title":"Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid","volume":"55","author":"Fernandez de Arriba","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0066|cit66","first-page":"155","article-title":"Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets","volume":"284","author":"Garc\u00eda-Rafanell","year":"1986","journal-title":"Archives Internationales de Pharmacodynamie et de Th\u00e9rapie"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/01.STR.31.7.1779","article-title":"Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials","volume":"31","author":"Hankey","year":"2000","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0069|cit69","first-page":"1669","article-title":"Comparative study of the effect of low-dosage acetylsalicylic acid and triflusal in the prevention of cardiovascular events among young adults with ischemic cerebrovascular disease","volume":"25","author":"Matias-Guiu","year":"1997","journal-title":"Revista de Neurologia"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"329b","DOI":"10.1161\/str.32.suppl_1.329-b","article-title":"Triflusal versus aspirin in secondary stroke prevention: results of TACIP study","volume":"32","author":"Mat\u00edas-Guiu","year":"2001","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000175892","article-title":"Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable","volume":"82","author":"Plaza","year":"1993","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2362.2000.00707.x","article-title":"A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function","volume":"30","author":"Sanchez de Miguel","year":"2000","journal-title":"European Journal of Clinical Investigation"},{"issue":"7197","key":"10.1002\/14651858.CD004296.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","article-title":"Numbers needed to treat derived from meta-analysis - sometimes informative, usually misleading","volume":"318","author":"Smeeth","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004296.pub2-BIB0074|cit74","first-page":"157","article-title":"The bias adjusted maximum likelihood estimate","volume-title":"The design and analysis of sequential clinical trials","author":"Whitehead","year":"1997"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004296.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:32:57Z","timestamp":1628544777000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004296.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2005,7,20]]},"references-count":74,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004296.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,20]]}}}